Medtronic was made aware of this event through a search of literature publications.It was not possible to ascertain specific device information from the literature publication or to match the event with previously reported events.This information is based entirely on journal literature.This event occurred outside the us.Patient information is limited due to confidentiality concerns.Since no device id was provided, it is unknown if this event has been previously reported.A request for additional information will be made and upon receipt a supplemental report will be submitted accordingly.Referenced article: ¿first-in-man fully leadless transvenous crt-p with a transseptal implant of wise-crt®system and micra®pm.¿ pace - pacing and clinical electrophysiology.2019; 42(11):1489-1492.Doi://10.1111/pace.13750.If information is provided in the future, a supplemental report will be issued.
|
A journal article was reviewed that contained information regarding a case study of the first fully leadless transvenous cardiac resynchronization therapy pacemaker (crt-p) implant with a leadless implantable pulse generator (ipg) implant.It was reported that with the patient's previous system, the patient experienced previous pocket infections, the most recent being due to staphylococcus epidermidis.The patient was treated with antibiotic therapy and a local dressing.Later the same year, the patient was hospitalized due to device exposure with signs of system infection by s.Epidermidis.The patient's lead was attempted to be extracted, however, the lead fractured and was left in place due to negative cultures tests on the extracted portion of the lead.The status of the extracted lead portion is unknown.Further follow up did not yet yield any additional information.No further patient complications have been reported as a result of this event.
|